Every 8-K that National Healthcare Properties, Inc. (NHP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow NHP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NHP filings page.
National Healthcare Properties, Inc. (NHP) reports that director Edward M. Weil, Jr. resigned from its board of directors, effective September 11, 2026. The company states that his decision to resign was not the result of any disagreement regarding its operations, policies, or practices.
National Healthcare Properties, Inc. (NHP) completed the first tranche of a previously announced sale of a portfolio of outpatient medical facilities. On September 10, 2026, the company, through subsidiaries of its operating partnership, closed on the sale of 30 properties out of an overall 86-facility portfolio to an unaffiliated buyer under a Purchase and Sale of Real Property Agreement dated May 4, 2026, as amended. The company received approximately $79 million in net cash proceeds at closing, before transaction expenses, property operating prorations and other adjustments. In connection with this transaction, it repaid approximately $119 million of outstanding secured indebtedness, including about $60 million of debt secured by other outpatient medical facilities that are not part of this portfolio. The company states that there are no material relationships between the seller entities and the buyer or their respective affiliates other than this sale.
National Healthcare Properties entered into a $1.2 billion amended and restated unsecured credit agreement with a $750 million revolving facility, $300 million term loan and $150 million delayed draw term loan, extended 2029–2030 maturities, an accordion of up to $1.0 billion and improved pricing, and used the recast to repay $332 million of Fannie Mae secured debt.
For Q2 2026, net loss attributable to common stockholders was $8.1 million, or $(0.13) per share, Nareit FFO was $0.19 per diluted share and Normalized FFO was $0.18 per diluted share, which decreased 18.2% year over year. Portfolio Same Store Cash NOI grew 6.8%, driven by the SHOP segment with 20.1% Same Store Cash NOI growth and 84.1% Same Store occupancy, while OMF Same Store Cash NOI decreased 0.4%.
Total debt was about $0.8 billion and Net Leverage improved to 4.9x from 9.2x a year earlier. The company completed or agreed to roughly $400 million of 2026 SHOP acquisitions, raised $531.3 million from its IPO of 44.3 million Class A shares, elected to redeem all 3,289,061 Series A and 2,850,427 Series B preferred shares at $25.32 and $25.47 per share including accrued dividends, and appointed experienced REIT executive Albert M. Campbell to its board and audit committee. Full-year 2026 guidance was updated, including higher expected SHOP Same Store Cash NOI growth of 15.0%–18.0%.
National Healthcare Properties, Inc. amended the executive employment agreement with its Chief Executive Officer and President, Michael Anderson. The amendment extends the agreement’s term from September 27, 2027 to September 27, 2030. After that date, the agreement will automatically renew for additional one-year periods unless either party gives written notice at least 90 days before the applicable term date. All other provisions, including compensatory terms, remain unchanged from those described in the company’s March 31, 2026 proxy statement.